 | • レポートコード：MRC2-11QY12653 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は更年期障害のグローバル市場について調査・分析したレポートです。種類別（エストロゲン、プロゲステロン、コンビネーション）市場規模、用途別（病院・クリニック、学術・研究機関、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別更年期障害の競争状況、市場シェア ・世界の更年期障害市場：種類別市場規模 2015年-2020年（エストロゲン、プロゲステロン、コンビネーション） ・世界の更年期障害市場：種類別市場規模予測 2021年-2026年（エストロゲン、プロゲステロン、コンビネーション） ・世界の更年期障害市場：用途別市場規模 2015年-2020年（病院・クリニック、学術・研究機関、その他） ・世界の更年期障害市場：用途別市場規模予測 2021年-2026年（病院・クリニック、学術・研究機関、その他） ・北米の更年期障害市場分析：米国、カナダ ・ヨーロッパの更年期障害市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの更年期障害市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の更年期障害市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの更年期障害市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Merck、Novartis、Novo Nordisk、Pfizer、Allergan、Emcure Pharmaceuticals、Eli Lilly And Company、Cipla、Teva Pharmaceutical Industries ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Menopause, also known as the climacteric, is the time in most women’s lives when menstrual periods stop permanently, and they are no longer able to bear children. Menopause typically occurs between 49 and 52 years of age. Medical professionals often define menopause as having occurred when a woman has not had any vaginal bleeding for a year. It may also be defined by a decrease in hormone production by the ovaries. In those who have had surgery to remove their uterus but still have ovaries, menopause may be viewed to have occurred at the time of the surgery or when their hormone levels fell. Following the removal of the uterus, symptoms typically occur earlier, at an average of 45 years of age.
Menopause is a natural stage of life. It is not a disease or a disorder. Therefore, it does not automatically require any kind of medical treatment. However, in those cases where the physical, mental, and emotional effects of perimenopause are strong enough that they significantly disrupt the life of the woman experiencing them, palliative medical therapy may sometimes be appropriate.
Market Analysis and Insights: Global Menopause Treatment Market
The global Menopause Treatment market size is projected to reach US$ 2586.6 million by 2026, from US$ 2521.7 million in 2020, at a CAGR of 2.4%% during 2021-2026.
Global Menopause Treatment Scope and Market Size
Menopause Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Menopause Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Merck
Novartis
Novo Nordisk
Pfizer
Allergan
Emcure Pharmaceuticals
Eli Lilly And Company
Cipla
Teva Pharmaceutical Industries
Market segment by Type, the product can be split into
Estrogen
Progesterone
Combination
Market segment by Application, split into
Hospitals & Clinics
Academic And Research Institutes
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Menopause Treatment Revenue
1.4 Market by Type
1.4.1 Global Menopause Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Estrogen
1.4.3 Progesterone
1.4.4 Combination
1.5 Market by Application
1.5.1 Global Menopause Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals & Clinics
1.5.3 Academic And Research Institutes
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Menopause Treatment Market Perspective (2015-2026)
2.2 Global Menopause Treatment Growth Trends by Regions
2.2.1 Menopause Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Menopause Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Menopause Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Menopause Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Menopause Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Menopause Treatment Players by Market Size
3.1.1 Global Top Menopause Treatment Players by Revenue (2015-2020)
3.1.2 Global Menopause Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Menopause Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Menopause Treatment Market Concentration Ratio
3.2.1 Global Menopause Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Menopause Treatment Revenue in 2019
3.3 Menopause Treatment Key Players Head office and Area Served
3.4 Key Players Menopause Treatment Product Solution and Service
3.5 Date of Enter into Menopause Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Menopause Treatment Historic Market Size by Type (2015-2020)
4.2 Global Menopause Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Menopause Treatment Market Size by Application (2015-2020)
5.2 Global Menopause Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Menopause Treatment Market Size (2015-2020)
6.2 Menopause Treatment Key Players in North America (2019-2020)
6.3 North America Menopause Treatment Market Size by Type (2015-2020)
6.4 North America Menopause Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Menopause Treatment Market Size (2015-2020)
7.2 Menopause Treatment Key Players in Europe (2019-2020)
7.3 Europe Menopause Treatment Market Size by Type (2015-2020)
7.4 Europe Menopause Treatment Market Size by Application (2015-2020)
8 China
8.1 China Menopause Treatment Market Size (2015-2020)
8.2 Menopause Treatment Key Players in China (2019-2020)
8.3 China Menopause Treatment Market Size by Type (2015-2020)
8.4 China Menopause Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Menopause Treatment Market Size (2015-2020)
9.2 Menopause Treatment Key Players in Japan (2019-2020)
9.3 Japan Menopause Treatment Market Size by Type (2015-2020)
9.4 Japan Menopause Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Menopause Treatment Market Size (2015-2020)
10.2 Menopause Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Menopause Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Menopause Treatment Market Size by Application (2015-2020)
11 India
11.1 India Menopause Treatment Market Size (2015-2020)
11.2 Menopause Treatment Key Players in India (2019-2020)
11.3 India Menopause Treatment Market Size by Type (2015-2020)
11.4 India Menopause Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Menopause Treatment Market Size (2015-2020)
12.2 Menopause Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Menopause Treatment Market Size by Type (2015-2020)
12.4 Central & South America Menopause Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Merck
13.1.1 Merck Company Details
13.1.2 Merck Business Overview
13.1.3 Merck Menopause Treatment Introduction
13.1.4 Merck Revenue in Menopause Treatment Business (2015-2020))
13.1.5 Merck Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview
13.2.3 Novartis Menopause Treatment Introduction
13.2.4 Novartis Revenue in Menopause Treatment Business (2015-2020)
13.2.5 Novartis Recent Development
13.3 Novo Nordisk
13.3.1 Novo Nordisk Company Details
13.3.2 Novo Nordisk Business Overview
13.3.3 Novo Nordisk Menopause Treatment Introduction
13.3.4 Novo Nordisk Revenue in Menopause Treatment Business (2015-2020)
13.3.5 Novo Nordisk Recent Development
13.4 Pfizer
13.4.1 Pfizer Company Details
13.4.2 Pfizer Business Overview
13.4.3 Pfizer Menopause Treatment Introduction
13.4.4 Pfizer Revenue in Menopause Treatment Business (2015-2020)
13.4.5 Pfizer Recent Development
13.5 Allergan
13.5.1 Allergan Company Details
13.5.2 Allergan Business Overview
13.5.3 Allergan Menopause Treatment Introduction
13.5.4 Allergan Revenue in Menopause Treatment Business (2015-2020)
13.5.5 Allergan Recent Development
13.6 Emcure Pharmaceuticals
13.6.1 Emcure Pharmaceuticals Company Details
13.6.2 Emcure Pharmaceuticals Business Overview
13.6.3 Emcure Pharmaceuticals Menopause Treatment Introduction
13.6.4 Emcure Pharmaceuticals Revenue in Menopause Treatment Business (2015-2020)
13.6.5 Emcure Pharmaceuticals Recent Development
13.7 Eli Lilly And Company
13.7.1 Eli Lilly And Company Company Details
13.7.2 Eli Lilly And Company Business Overview
13.7.3 Eli Lilly And Company Menopause Treatment Introduction
13.7.4 Eli Lilly And Company Revenue in Menopause Treatment Business (2015-2020)
13.7.5 Eli Lilly And Company Recent Development
13.8 Cipla
13.8.1 Cipla Company Details
13.8.2 Cipla Business Overview
13.8.3 Cipla Menopause Treatment Introduction
13.8.4 Cipla Revenue in Menopause Treatment Business (2015-2020)
13.8.5 Cipla Recent Development
13.9 Teva Pharmaceutical Industries
13.9.1 Teva Pharmaceutical Industries Company Details
13.9.2 Teva Pharmaceutical Industries Business Overview
13.9.3 Teva Pharmaceutical Industries Menopause Treatment Introduction
13.9.4 Teva Pharmaceutical Industries Revenue in Menopause Treatment Business (2015-2020)
13.9.5 Teva Pharmaceutical Industries Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Menopause Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Menopause Treatment Revenue
Table 3. Ranking of Global Top Menopause Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Menopause Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Estrogen
Table 6. Key Players of Progesterone
Table 7. Key Players of Combination
Table 8. Global Menopause Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Menopause Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Menopause Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Menopause Treatment Market Share by Regions (2015-2020)
Table 12. Global Menopause Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Menopause Treatment Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Menopause Treatment Market Growth Strategy
Table 18. Main Points Interviewed from Key Menopause Treatment Players
Table 19. Global Menopause Treatment Revenue by Players (2015-2020) (Million US$)
Table 20. Global Menopause Treatment Market Share by Players (2015-2020)
Table 21. Global Top Menopause Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Menopause Treatment as of 2019)
Table 22. Global Menopause Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Menopause Treatment Product Solution and Service
Table 25. Date of Enter into Menopause Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Menopause Treatment Market Size by Type (2015-2020) (Million US$)
Table 28. Global Menopause Treatment Market Size Share by Type (2015-2020)
Table 29. Global Menopause Treatment Revenue Market Share by Type (2021-2026)
Table 30. Global Menopause Treatment Market Size Share by Application (2015-2020)
Table 31. Global Menopause Treatment Market Size by Application (2015-2020) (Million US$)
Table 32. Global Menopause Treatment Market Size Share by Application (2021-2026)
Table 33. North America Key Players Menopause Treatment Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Menopause Treatment Market Share (2019-2020)
Table 35. North America Menopause Treatment Market Size by Type (2015-2020) (Million US$)
Table 36. North America Menopause Treatment Market Share by Type (2015-2020)
Table 37. North America Menopause Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. North America Menopause Treatment Market Share by Application (2015-2020)
Table 39. Europe Key Players Menopause Treatment Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Menopause Treatment Market Share (2019-2020)
Table 41. Europe Menopause Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Menopause Treatment Market Share by Type (2015-2020)
Table 43. Europe Menopause Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Menopause Treatment Market Share by Application (2015-2020)
Table 45. China Key Players Menopause Treatment Revenue (2019-2020) (Million US$)
Table 46. China Key Players Menopause Treatment Market Share (2019-2020)
Table 47. China Menopause Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. China Menopause Treatment Market Share by Type (2015-2020)
Table 49. China Menopause Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. China Menopause Treatment Market Share by Application (2015-2020)
Table 51. Japan Key Players Menopause Treatment Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Menopause Treatment Market Share (2019-2020)
Table 53. Japan Menopause Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Menopause Treatment Market Share by Type (2015-2020)
Table 55. Japan Menopause Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Menopause Treatment Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Menopause Treatment Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Menopause Treatment Market Share (2019-2020)
Table 59. Southeast Asia Menopause Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Menopause Treatment Market Share by Type (2015-2020)
Table 61. Southeast Asia Menopause Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Menopause Treatment Market Share by Application (2015-2020)
Table 63. India Key Players Menopause Treatment Revenue (2019-2020) (Million US$)
Table 64. India Key Players Menopause Treatment Market Share (2019-2020)
Table 65. India Menopause Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. India Menopause Treatment Market Share by Type (2015-2020)
Table 67. India Menopause Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. India Menopause Treatment Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Menopause Treatment Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Menopause Treatment Market Share (2019-2020)
Table 71. Central & South America Menopause Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Menopause Treatment Market Share by Type (2015-2020)
Table 73. Central & South America Menopause Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Menopause Treatment Market Share by Application (2015-2020)
Table 75. Merck Company Details
Table 76. Merck Business Overview
Table 77. Merck Product
Table 78. Merck Revenue in Menopause Treatment Business (2015-2020) (Million US$)
Table 79. Merck Recent Development
Table 80. Novartis Company Details
Table 81. Novartis Business Overview
Table 82. Novartis Product
Table 83. Novartis Revenue in Menopause Treatment Business (2015-2020) (Million US$)
Table 84. Novartis Recent Development
Table 85. Novo Nordisk Company Details
Table 86. Novo Nordisk Business Overview
Table 87. Novo Nordisk Product
Table 88. Novo Nordisk Revenue in Menopause Treatment Business (2015-2020) (Million US$)
Table 89. Novo Nordisk Recent Development
Table 90. Pfizer Company Details
Table 91. Pfizer Business Overview
Table 92. Pfizer Product
Table 93. Pfizer Revenue in Menopause Treatment Business (2015-2020) (Million US$)
Table 94. Pfizer Recent Development
Table 95. Allergan Company Details
Table 96. Allergan Business Overview
Table 97. Allergan Product
Table 98. Allergan Revenue in Menopause Treatment Business (2015-2020) (Million US$)
Table 99. Allergan Recent Development
Table 100. Emcure Pharmaceuticals Company Details
Table 101. Emcure Pharmaceuticals Business Overview
Table 102. Emcure Pharmaceuticals Product
Table 103. Emcure Pharmaceuticals Revenue in Menopause Treatment Business (2015-2020) (Million US$)
Table 104. Emcure Pharmaceuticals Recent Development
Table 105. Eli Lilly And Company Company Details
Table 106. Eli Lilly And Company Business Overview
Table 107. Eli Lilly And Company Product
Table 108. Eli Lilly And Company Revenue in Menopause Treatment Business (2015-2020) (Million US$)
Table 109. Eli Lilly And Company Recent Development
Table 110. Cipla Business Overview
Table 111. Cipla Product
Table 112. Cipla Company Details
Table 113. Cipla Revenue in Menopause Treatment Business (2015-2020) (Million US$)
Table 114. Cipla Recent Development
Table 115. Teva Pharmaceutical Industries Company Details
Table 116. Teva Pharmaceutical Industries Business Overview
Table 117. Teva Pharmaceutical Industries Product
Table 118. Teva Pharmaceutical Industries Revenue in Menopause Treatment Business (2015-2020) (Million US$)
Table 119. Teva Pharmaceutical Industries Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Menopause Treatment Market Share by Type: 2020 VS 2026
Figure 2. Estrogen Features
Figure 3. Progesterone Features
Figure 4. Combination Features
Figure 5. Global Menopause Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospitals & Clinics Case Studies
Figure 7. Academic And Research Institutes Case Studies
Figure 8. Others Case Studies
Figure 9. Menopause Treatment Report Years Considered
Figure 10. Global Menopause Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Menopause Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Menopause Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Menopause Treatment Market Share by Players in 2019
Figure 15. Global Top Menopause Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Menopause Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Menopause Treatment Revenue in 2019
Figure 17. North America Menopause Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Menopause Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Menopause Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Menopause Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Menopause Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Menopause Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Menopause Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
更年期における血管運動性症状治療の世界市場（～2026年） Market Analysis and Insights: Global Vasomotor Symptoms of Menopause Treatment Market The global Vasomotor Symptoms of Menopause Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Vasomotor Symptoms of Menopause…- 美容における併用療法の世界市場（～2026年） Combination treatment in aesthetics consists of multiple treatment approaches for improving aesthetic appearance for consumer. It involves both minimally invasive and virtually noninvasive treatment approaches. Combination treatment in aesthetics works on the principle that single modality of treatm…
- カルシフィラキシス治療の世界市場（～2026年） Calciphylaxis, also known as calcific uremic arteriolopathy (CUA), is a rare condition characterized by calcification or the aggregation of calcium in a patient’s blood vessels and the development of thrombosis. This can lead to the death of cells in a patient’s skin and fatty tissues, thereby causi…
- 乳管内乳頭腫治療の世界市場（～2026年） An intraductal papilloma is a benign, or noncancerous, breast tumour that forms in a milk duct and is made of gland and fibrous tissue as well as blood vessels. These generally appear as lumps after breast examination and may cause nipple discharge or bleeding. Intraductal papilloma most commonly oc…
- 口腔がん治療の世界市場（～2026年） Oral cancer, also known as mouth cancer, is a type of head and neck cancer and is any cancerous tissue growth located in the oral cavity. It may arise as a primary lesion originating in any of the tissues in the mouth, by metastasis from a distant site of origin, or by extension from a neighboring a…